Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ain Uustare

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|August 29, 2006
Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteinsAin Uustare, Reet Reinart, Ago Rinken
Neurochemistry International|September 16, 2003
Characterization of M2 muscarinic receptor activation of different G protein subtypesAin Uustare, Johnny Näsman, Karl E O Akerman, et al.
Life Sciences|February 1, 2005
Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptorsAin Uustare, Argo Vonk, Anton Terasmaa, et al.
Bioorganic & Medicinal Chemistry|March 4, 2008
Synthesis and neuropharmacological characterization of 2-O-substituted apomorphinesAttila Sipos, Csaba Csutorás, Sándor Berényi, et al.
Bioorganic & Medicinal Chemistry|June 4, 2013
1-substituted apomorphines as potent dopamine agonistsReet Reinart-Okugbeni, Argo Vonk, Ain Uustare, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Novel Anthracycline Utorubicin for Cancer TherapyLorena Simón-Gracia, Valeria Sidorenko, Ain Uustare, et al.
Angewandte Chemie (International Ed. in English)|April 28, 2021
Novel Anthracycline Utorubicin for Cancer TherapyLorena Simón-Gracia, Valeria Sidorenko, Ain Uustare, et al.
Brain Research|January 8, 2008
Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activityTanel Mällo, Kadri Kõiv, Indrek Koppel, et al.
Scientific Reports|July 30, 2024
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapyValeria Sidorenko, Pablo Scodeller, Ain Uustare, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|August 29, 2006
Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteinsAin Uustare, Reet Reinart, Ago Rinken
Neurochemistry International|September 16, 2003
Characterization of M2 muscarinic receptor activation of different G protein subtypesAin Uustare, Johnny Näsman, Karl E O Akerman, et al.
Life Sciences|February 1, 2005
Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptorsAin Uustare, Argo Vonk, Anton Terasmaa, et al.
Bioorganic & Medicinal Chemistry|March 4, 2008
Synthesis and neuropharmacological characterization of 2-O-substituted apomorphinesAttila Sipos, Csaba Csutorás, Sándor Berényi, et al.
Bioorganic & Medicinal Chemistry|June 4, 2013
1-substituted apomorphines as potent dopamine agonistsReet Reinart-Okugbeni, Argo Vonk, Ain Uustare, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Novel Anthracycline Utorubicin for Cancer TherapyLorena Simón-Gracia, Valeria Sidorenko, Ain Uustare, et al.
Angewandte Chemie (International Ed. in English)|April 28, 2021
Novel Anthracycline Utorubicin for Cancer TherapyLorena Simón-Gracia, Valeria Sidorenko, Ain Uustare, et al.
Brain Research|January 8, 2008
Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activityTanel Mällo, Kadri Kõiv, Indrek Koppel, et al.
Scientific Reports|July 30, 2024
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapyValeria Sidorenko, Pablo Scodeller, Ain Uustare, et al.
Pageof 1